Investor search results
427 investors found
🌍 United States🏷 Clinical Trials
Popular searches

Alaa Halawa
Investing in and building transformative companies at the intersection of technology and healthcare
3
in Clinical Trials

Shawn Tomasello
Board Member, Board Chair, Former CEO, Advisor, Former CCO, Biotech Innovator, Change Agent
3
in Clinical Trials

Kevin Han
Growth Equity & Private Credit @ Morgan Stanley | Healthcare Advisor & Executive | Life Sciences | MedTech | Tools/Dx | Digital Health | Health Tech
3
in Clinical Trials
Frequently asked questions about Clinical Trials investors in United States
How many Clinical Trials investors are there in United States?
Gritt tracks 423 Clinical Trials investors in United States, of which 327 (77%) have a direct email address available.
How can I contact Clinical Trials investors in United States?
Gritt provides direct email addresses for 77% of investors in this list. On a paid plan you can unlock them and export the list, or use Gritt AI outreach to draft personalised emails that you approve, or let Gritt approve, and send from your Gmail.
Are these investors actively investing in United States startups?
Gritt lists them most active first, by the number of deals they have made in Clinical Trials, and each profile shows those deals and their dates. To see only investors who have invested recently, use the Last active filter.
Can I filter by investment stage or industry?
Yes — use the filters on the left to narrow by investment stage (early, mid, late) or industry. You can also filter by last active date to focus on investors who have made deals recently.
Can I export this list of Clinical Trials investors in United States?
Yes — paid Gritt accounts can export any filtered investor list as a CSV, including names, email addresses, LinkedIn profiles and investment counts.
Contact all 423 Clinical Trials investors
Gritt drafts a personalised AI email for each — written from your pitch; you approve each one, or let Gritt approve them for you, and it sends from your Gmail.
Start free — contact these investors



